DLA
BMY.RT
Douglas Lane & Associates’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,000
| Closed | – | – | 236 |
|
|
2021
Q2 | $0 | Buy |
+10,000
| New | – | ﹤0.01% | 231 |
|
|
2021
Q1 | – | Sell |
-523,445
| Closed | -$361K | – | 222 |
|
|
2020
Q4 | $361K | Sell |
523,445
-69,416
| -12% | -$47.9K | 0.01% | 174 |
|
|
2020
Q3 | $1.33M | Sell |
592,861
-39,109
| -6% | -$88K | 0.03% | 130 |
|
|
2020
Q2 | $2.26M | Sell |
631,970
-65,439
| -9% | -$234K | 0.05% | 117 |
|
|
2020
Q1 | $2.65M | Sell |
697,409
-17,283
| -2% | -$65.7K | 0.07% | 113 |
|
|
2019
Q4 | $2.15M | Buy |
+714,692
| New | +$2.15M | 0.04% | 124 |
|